Abbott Laboratories

Medical Devices for Remote Patient Monitoring of Chronic Conditions

Rising healthcare costs, an aging population and an increasing prevalence of chronic diseases are driving the uptake of remote patient monitoring (RPM) technologies. In their recent report, Remote Patient Monitoring 2023 - 2033: Technologies, Markets and Opportunities, IDTechEx forecasts the market for medical devices supporting RPM to reach US$45 billion by 2033.

Infinovo

Infinovo are a company developing CGM for diabetics. The company was only founded in 2016 and is based in Suzhou, China.

PKVitality

PKVitality are developing a non-invasive continuous glucose monitor using a microneedle-based skin patch and watch. Tess Skyrme, Technology Analyst at IDTechEx, interviewed Minh Le, General Manager of the company, to get an update from the company.

AbbVie

AbbVie is a biopharmaceutical company, spun out of Abbott Laboratories in 2013.

The Waning COVID-19 Pandemic's Lasting Effect on Point-Of-Care

COVID-19 testing at point of care peaked in Q1 2022. Is testing waning? What is COVID-19's lasting effect on point-of-care testing?

Diabetes Technology Market: Continuous Glucose Monitors Drives Growth

By the year 2032, IDTechEx predicts the test strip industry to make up only 6.7% of the overall diabetes management device market, down from a peak of 63.4% in 2010.

Know Labs

Know Labs is a US-based company developing non-invasive glucose monitoring devices based on its proprietary technology called Bio-RFID. IDTechEx analyst Brendan Beh interviewed Know Labs Chairman Ron Erickson on the 25th of January, 2022.

Fitscript

Fitscript is a digital health company looking at diabetes management via exercise therapy. IDTechEx analysts Brendan Beh and Dr Nadia Tsao interviewed Fitscript Chief Clinical Strategy Officer LaurieAnn Scher on the 22nd of November, 2021.

SNAQ

SNAQ is a digital health startup commercializing a AI-enabled logbook for food tracking. IDTechEx analysts Nadia Tsao and Brendan Beh interviewed SNAQ CEO Aurelian Briner on 17 Nov 2021.

A Persoanlised Exoskeleton for Real-World Walking

Researchers have developed a new approach in which robotic exosuit assistance can be calibrated to an individual and adapt to a variety of real-world walking tasks in a matter of seconds. The bioinspired system uses ultrasound measurements of muscle dynamics to develop a personalized and activity-specific assistance profile for users of the exosuit.

Medtronic

At Cardio Wearables 2021, Dr Rohan Sonawane, Sr Medical Affairs Program Manager, presented Medronic's product offerings in the cardiac rhythm space, focusing on their Reveal LINQ™ implantable cardiac monitor.

Quantum Operation

Quantum Operation is a Japanese start up working on a non-invasive continuous glucose monitor. The company attended CES 2021.

Skin Patches & e-Textiles at CES 2021

This premium article covers the major launches and themes in the niche wearable technology product areas of skin patches and e-textiles. Despite the "consumer" focus of the event, much of the discussion and product launches of note focused around health and wellness applications, including products on both the consumer and medical side of the regulatory barriers. This article reviews some of the prominent announcements and companies present at this year's virtual event.

First Scottish Hydrogen-Powered Train by November

A consortium is set to deliver Scotland's first hydrogen powered train. A key objective of the project is to create opportunities for the Scottish rail supply chain through skills development and industrialisation of the technology.

First Glucose Biosensor Designed for Athletes

Libre Sense Glucose Sport Biosensor is a consumer over-the-counter product that provides glucose monitoring via a mobile app o athletes performing sports such as cycling, running, and swimming, to understand the efficacy of their nutrition choices on training and competition.